Free Trial
NASDAQ:SRZN

Surrozen (SRZN) Stock Price, News & Analysis

Surrozen logo
$9.15 -0.15 (-1.61%)
(As of 11/22/2024 ET)

About Surrozen Stock (NASDAQ:SRZN)

Key Stats

Today's Range
$8.78
$9.92
50-Day Range
$8.01
$13.44
52-Week Range
$6.00
$16.19
Volume
9,333 shs
Average Volume
30,945 shs
Market Capitalization
$29.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.

Surrozen Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
29th Percentile Overall Score

SRZN MarketRank™: 

Surrozen scored higher than 29% of companies evaluated by MarketBeat, and ranked 803rd out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Surrozen.

  • Earnings Growth

    Earnings for Surrozen are expected to grow in the coming year, from ($7.16) to ($4.15) per share.

  • Price to Book Value per Share Ratio

    Surrozen has a P/B Ratio of 5.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Surrozen's valuation and earnings.
  • Percentage of Shares Shorted

    1.47% of the float of Surrozen has been sold short.
  • Short Interest Ratio / Days to Cover

    Surrozen has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Surrozen has recently decreased by 21.57%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Surrozen does not currently pay a dividend.

  • Dividend Growth

    Surrozen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.47% of the float of Surrozen has been sold short.
  • Short Interest Ratio / Days to Cover

    Surrozen has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Surrozen has recently decreased by 21.57%, indicating that investor sentiment is improving significantly.
  • Search Interest

    1 people have searched for SRZN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surrozen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    43.50% of the stock of Surrozen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.57% of the stock of Surrozen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Surrozen's insider trading history.
Receive SRZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surrozen and its competitors with MarketBeat's FREE daily newsletter.

SRZN Stock News Headlines

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Surrozen, TCGFB announce strategic research collaboration
See More Headlines

SRZN Stock Analysis - Frequently Asked Questions

Surrozen's stock was trading at $9.40 at the beginning of the year. Since then, SRZN shares have decreased by 2.7% and is now trading at $9.15.
View the best growth stocks for 2024 here
.

Surrozen, Inc. (NASDAQ:SRZN) posted its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($2.77) by $2.33. The business earned $10 million during the quarter.

Surrozen's stock reverse split before market open on Thursday, December 14th 2023. The 1-15 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Surrozen's top institutional shareholders include Stonepine Capital Management LLC (3.43%).
View institutional ownership trends
.

Shares of SRZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surrozen investors own include ACADIA Pharmaceuticals (ACAD), Marvell Technology (MRVL), HubSpot (HUBS), Avidity Biosciences (RNA), Adverum Biotechnologies (ADVM), Alpha and Omega Semiconductor (AOSL) and Domino's Pizza (DPZ).

Company Calendar

Last Earnings
11/06/2024
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
4/09/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SRZN
Fax
N/A
Employees
42
Year Founded
N/A

Profitability

Net Income
$-43,040,000.00
Pretax Margin
-444.38%

Debt

Sales & Book Value

Annual Sales
$12.50 million
Book Value
$1.74 per share

Miscellaneous

Free Float
1,836,000
Market Cap
$29.74 million
Optionable
Not Optionable
Beta
0.91
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:SRZN) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners